Kelleher Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

Kelleher Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74K	Buy	+207	New	+$1.73K	﹤0.01%	770

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Kelleher Financial Advisors's EBS Position: Q2 2026 in Review

Kelleher Financial Advisors opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 207 shares worth $1.74K. The stake represents ﹤0.01% of the portfolio and ranks #770 among its holdings.

195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Kelleher Financial Advisors held 207 shares of Emergent Biosolutions worth $1.74K as of Q2 2026.
Emergent Biosolutions was a new Kelleher Financial Advisors position in Q2 2026.
Emergent Biosolutions made up ﹤0.01% of Kelleher Financial Advisors's portfolio in Q2 2026, its #770 holding.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.